These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
Form 10-Q
|
(Mark One)
|
|
ý
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
¨
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Delaware
|
|
75-2559681
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. employer
identification no.)
|
|
Large accelerated filer
|
ý
|
|
|
Accelerated filer
|
¨
|
|
|
|
|
||
Non-accelerated filer
|
¨
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
¨
|
|
|
|
Page
|
|
|
|
|
|
|
Item 1
|
—
|
|
||
Item 2
|
—
|
|
||
Item 3
|
—
|
|
||
Item 4
|
—
|
|
||
|
|
|
|
|
|
|
|
|
|
Item 1
|
—
|
|
||
Item 1A
|
—
|
|
||
Item 6
|
—
|
|
||
|
|
|
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
31,582
|
|
|
$
|
17,980
|
|
Receivables, net of allowances of $4,810 and $5,118
|
646,648
|
|
|
669,200
|
|
||
Income tax receivable
|
5,147
|
|
|
5,578
|
|
||
Inventories
|
290,908
|
|
|
284,484
|
|
||
Deferred income taxes
|
—
|
|
|
37,504
|
|
||
Prepaid expenses and other current assets
|
37,088
|
|
|
43,884
|
|
||
Total current assets
|
1,011,373
|
|
|
1,058,630
|
|
||
Property, plant and equipment, net
|
1,135,724
|
|
|
1,163,851
|
|
||
Goodwill
|
154,112
|
|
|
154,112
|
|
||
Identifiable intangible and other assets, net
|
201,044
|
|
|
207,897
|
|
||
Deferred income taxes
|
23,487
|
|
|
21,737
|
|
||
Total
|
$
|
2,525,740
|
|
|
$
|
2,606,227
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable and accrued expenses
|
$
|
684,471
|
|
|
$
|
706,981
|
|
Current portion of debt
|
141,482
|
|
|
140,806
|
|
||
Total current liabilities
|
825,953
|
|
|
847,787
|
|
||
Long-term debt, net
|
750,195
|
|
|
745,245
|
|
||
Deferred income taxes
|
86,520
|
|
|
126,009
|
|
||
Other long-term liabilities
|
268,045
|
|
|
276,630
|
|
||
Commitments and contingencies (Note 12)
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
||||
Preferred stock, none issued
|
—
|
|
|
—
|
|
||
Common stock, 90,872,751 and 90,586,741 shares issued and outstanding, with a par value of $0.01 per share
|
909
|
|
|
906
|
|
||
Additional paid-in capital
|
654,513
|
|
|
653,629
|
|
||
Retained earnings
|
27,594
|
|
|
45,654
|
|
||
Accumulated other comprehensive loss
|
(87,989
|
)
|
|
(89,633
|
)
|
||
Total stockholders’ equity
|
595,027
|
|
|
610,556
|
|
||
Total
|
$
|
2,525,740
|
|
|
$
|
2,606,227
|
|
|
Three Months Ended
March 31 |
||||||
|
2017
|
|
2016
|
||||
Net sales
|
$
|
1,995,686
|
|
|
$
|
1,878,828
|
|
Cost of sales
|
1,533,561
|
|
|
1,374,760
|
|
||
Gross profit
|
462,125
|
|
|
504,068
|
|
||
Operating costs and expenses:
|
|
|
|
||||
Selling and distribution
|
345,196
|
|
|
332,887
|
|
||
General and administrative
|
99,536
|
|
|
85,151
|
|
||
Amortization of intangibles
|
5,155
|
|
|
6,325
|
|
||
Facility closing and reorganization costs, net
|
9,286
|
|
|
1,166
|
|
||
Total operating costs and expenses
|
459,173
|
|
|
425,529
|
|
||
Operating income
|
2,952
|
|
|
78,539
|
|
||
Other (income) expense:
|
|
|
|
||||
Interest expense
|
17,464
|
|
|
16,876
|
|
||
Other income, net
|
(956
|
)
|
|
(997
|
)
|
||
Total other expense
|
16,508
|
|
|
15,879
|
|
||
Income (loss) before income taxes
|
(13,556
|
)
|
|
62,660
|
|
||
Income tax expense (benefit)
|
(3,797
|
)
|
|
23,459
|
|
||
Net income (loss)
|
$
|
(9,759
|
)
|
|
$
|
39,201
|
|
Average common shares:
|
|
|
|
||||
Basic
|
90,709,802
|
|
|
91,567,119
|
|
||
Diluted
|
90,709,802
|
|
|
92,168,303
|
|
||
Basic income (loss) per common share:
|
|
|
|
||||
Net income (loss)
|
$
|
(0.11
|
)
|
|
$
|
0.43
|
|
Diluted income (loss) per common share:
|
|
|
|
||||
Net income (loss)
|
$
|
(0.11
|
)
|
|
$
|
0.43
|
|
Cash dividends declared per common share
|
$
|
0.09
|
|
|
$
|
0.09
|
|
|
Three Months Ended
March 31 |
||||||
|
2017
|
|
2016
|
||||
Net income (loss)
|
$
|
(9,759
|
)
|
|
$
|
39,201
|
|
Other comprehensive income (loss):
|
|
|
|
||||
Cumulative translation adjustments
|
—
|
|
|
153
|
|
||
Pension and other postretirement liability adjustment, net of tax
|
1,644
|
|
|
1,485
|
|
||
Other comprehensive income
|
1,644
|
|
|
1,638
|
|
||
Comprehensive income (loss)
|
$
|
(8,115
|
)
|
|
$
|
40,839
|
|
|
Common Stock
|
|
|
|
Retained Earnings
|
|
Accumulated Other
Comprehensive Income (Loss) |
|
Total
Stockholders’
Equity
|
|||||||||||||
|
Shares
|
|
Amount
|
|
Additional
Paid-In Capital
|
|
|
|
||||||||||||||
Balance, January 1, 2017
|
90,586,741
|
|
|
$
|
906
|
|
|
$
|
653,629
|
|
|
$
|
45,654
|
|
|
$
|
(89,633
|
)
|
|
$
|
610,556
|
|
Issuance of common stock
|
286,010
|
|
|
3
|
|
|
(1,224
|
)
|
|
—
|
|
|
—
|
|
|
(1,221
|
)
|
|||||
Share-based compensation expense
|
—
|
|
|
—
|
|
|
2,108
|
|
|
—
|
|
|
—
|
|
|
2,108
|
|
|||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,759
|
)
|
|
—
|
|
|
(9,759
|
)
|
|||||
Dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,301
|
)
|
|
—
|
|
|
(8,301
|
)
|
|||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Pension and other postretirement benefit liability adjustment, net of tax of $1,022
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,644
|
|
|
1,644
|
|
|||||
Balance, March 31, 2017
|
90,872,751
|
|
|
$
|
909
|
|
|
$
|
654,513
|
|
|
$
|
27,594
|
|
|
$
|
(87,989
|
)
|
|
$
|
595,027
|
|
|
Common Stock
|
|
|
|
Retained
|
|
Accumulated
|
|
Total
Stockholders’
Equity
|
|||||||||||||
|
Shares
|
|
Amount
|
|
Additional
Paid-In Capital
|
|
Earnings
(Accumulated
Deficit)
|
|
Other
Comprehensive
Income (Loss)
|
|||||||||||||
Balance, January 1, 2016
|
91,428,274
|
|
|
$
|
914
|
|
|
$
|
679,916
|
|
|
$
|
(49,523
|
)
|
|
$
|
(85,803
|
)
|
|
$
|
545,504
|
|
Issuance of common stock, net of tax impact of share-based compensation
|
338,017
|
|
|
4
|
|
|
(1,765
|
)
|
|
—
|
|
|
—
|
|
|
(1,761
|
)
|
|||||
Share-based compensation expense
|
—
|
|
|
—
|
|
|
1,756
|
|
|
—
|
|
|
—
|
|
|
1,756
|
|
|||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
39,201
|
|
|
—
|
|
|
39,201
|
|
|||||
Dividends
|
—
|
|
|
—
|
|
|
(8,390
|
)
|
|
—
|
|
|
—
|
|
|
(8,390
|
)
|
|||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cumulative translation adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
153
|
|
|
153
|
|
|||||
Pension and other postretirement benefit liability adjustment, net of tax of $897
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,485
|
|
|
1,485
|
|
|||||
Balance, March 31, 2016
|
91,766,291
|
|
|
$
|
918
|
|
|
$
|
671,517
|
|
|
$
|
(10,322
|
)
|
|
$
|
(84,165
|
)
|
|
$
|
577,948
|
|
|
Three Months Ended
March 31 |
||||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income (loss)
|
$
|
(9,759
|
)
|
|
$
|
39,201
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
43,191
|
|
|
45,038
|
|
||
Share-based compensation expense
|
3,957
|
|
|
6,067
|
|
||
(Gain) loss on divestitures and other, net
|
1,161
|
|
|
(2,404
|
)
|
||
Write-off of financing costs
|
1,080
|
|
|
—
|
|
||
Deferred income taxes
|
(4,757
|
)
|
|
5,295
|
|
||
Other, net
|
4,525
|
|
|
(1,171
|
)
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Receivables, net
|
22,552
|
|
|
54,915
|
|
||
Inventories
|
(6,424
|
)
|
|
(16,059
|
)
|
||
Prepaid expenses and other assets
|
6,632
|
|
|
11,596
|
|
||
Accounts payable and accrued expenses
|
(35,033
|
)
|
|
(114,955
|
)
|
||
Income taxes receivable/payable
|
431
|
|
|
18,707
|
|
||
Net cash provided by operating activities
|
27,556
|
|
|
46,230
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Payments for property, plant and equipment
|
(8,372
|
)
|
|
(17,067
|
)
|
||
Proceeds from sale of fixed assets
|
1,001
|
|
|
3,209
|
|
||
Net cash used in investing activities
|
(7,371
|
)
|
|
(13,858
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Repayments of debt
|
(600
|
)
|
|
(413
|
)
|
||
Payments of financing costs
|
(1,709
|
)
|
|
—
|
|
||
Proceeds from senior secured revolver
|
54,300
|
|
|
—
|
|
||
Payments for senior secured revolver
|
(59,000
|
)
|
|
—
|
|
||
Proceeds from receivables securitization facility
|
535,000
|
|
|
—
|
|
||
Payments for receivables securitization facility
|
(525,000
|
)
|
|
—
|
|
||
Cash dividends paid
|
(8,178
|
)
|
|
(8,259
|
)
|
||
Issuance of common stock, net of share repurchases for withholding taxes
|
(1,396
|
)
|
|
(663
|
)
|
||
Tax savings on share-based compensation
|
—
|
|
|
758
|
|
||
Net cash used in financing activities
|
(6,583
|
)
|
|
(8,577
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
—
|
|
|
66
|
|
||
Increase in cash and cash equivalents
|
13,602
|
|
|
23,861
|
|
||
Cash and cash equivalents, beginning of period
|
17,980
|
|
|
60,734
|
|
||
Cash and cash equivalents, end of period
|
$
|
31,582
|
|
|
$
|
84,595
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
(In thousands)
|
||||||
Raw materials and supplies
|
$
|
104,464
|
|
|
$
|
110,095
|
|
Finished goods
|
186,444
|
|
|
174,389
|
|
||
Total
|
$
|
290,908
|
|
|
$
|
284,484
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||||||||||
|
Acquisition Costs
|
|
Impairment
|
|
Accumulated
Amortization
|
|
Net
Carrying
Amount
|
|
Acquisition Costs
|
|
Impairment
|
|
Accumulated
Amortization
|
|
Net
Carrying
Amount
|
||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||
Intangible assets with indefinite lives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Trademarks
|
$
|
52,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
52,000
|
|
|
$
|
52,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
52,000
|
|
Intangible assets with finite lives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Customer-related and other
|
78,925
|
|
|
—
|
|
|
(38,131
|
)
|
|
40,794
|
|
|
78,925
|
|
|
—
|
|
|
(37,050
|
)
|
|
41,875
|
|
||||||||
Trademarks
|
229,777
|
|
|
(109,910
|
)
|
|
(45,899
|
)
|
|
73,968
|
|
|
229,777
|
|
|
(109,910
|
)
|
|
(41,824
|
)
|
|
78,043
|
|
||||||||
Total
|
$
|
360,702
|
|
|
$
|
(109,910
|
)
|
|
$
|
(84,030
|
)
|
|
$
|
166,762
|
|
|
$
|
360,702
|
|
|
$
|
(109,910
|
)
|
|
$
|
(78,874
|
)
|
|
$
|
171,918
|
|
2017
|
$
|
20.6
|
|
2018
|
20.0
|
|
|
2019
|
20.0
|
|
|
2020
|
11.9
|
|
|
2021
|
10.2
|
|
|
March 31, 2017
|
|
|
December 31, 2016
|
|
||||||||
|
Amount
|
|
Interest
Rate
|
|
|
Amount
|
|
Interest
Rate
|
|
||||
|
(In thousands, except percentages)
|
|
|||||||||||
Dean Foods Company debt obligations:
|
|
|
|
|
|
|
|
|
|
||||
Senior secured revolving credit facility
|
$
|
4,400
|
|
|
2.91
|
% *
|
|
$
|
9,100
|
|
|
2.94
|
% *
|
Senior notes due 2023
|
700,000
|
|
|
6.50
|
|
|
700,000
|
|
|
6.50
|
|
||
|
704,400
|
|
|
|
|
|
709,100
|
|
|
|
|
||
Subsidiary debt obligations:
|
|
|
|
|
|
|
|
|
|
||||
Senior notes due 2017
|
142,000
|
|
|
6.90
|
|
|
142,000
|
|
|
6.90
|
|
||
Receivables securitization facility
|
50,000
|
|
|
1.93
|
*
|
|
40,000
|
|
|
1.87
|
*
|
||
Capital lease and other
|
3,380
|
|
|
—
|
|
|
3,980
|
|
|
—
|
|
||
|
195,380
|
|
|
|
|
|
185,980
|
|
|
|
|
||
Subtotal
|
899,780
|
|
|
|
|
|
895,080
|
|
|
|
|
||
Unamortized discounts and debt issuance costs
|
(8,103
|
)
|
|
|
|
|
(9,029
|
)
|
|
|
|
||
Total debt
|
891,677
|
|
|
|
|
|
886,051
|
|
|
|
|
||
Less current portion
|
(141,482
|
)
|
|
|
|
|
(140,806
|
)
|
|
|
|
||
Total long-term portion
|
$
|
750,195
|
|
|
|
|
|
$
|
745,245
|
|
|
|
|
2017
|
$
|
142,689
|
|
2018
|
1,125
|
|
|
2019
|
1,174
|
|
|
2020
|
50,392
|
|
|
2021
|
—
|
|
|
Thereafter
|
704,400
|
|
|
Subtotal
|
899,780
|
|
|
Less unamortized discounts and debt issuance costs
|
(8,103
|
)
|
|
Total debt
|
$
|
891,677
|
|
|
Derivative Assets
|
|
Derivative Liabilities
|
||||||||||||
|
March 31, 2017
|
|
December 31, 2016
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||
|
(In thousands)
|
||||||||||||||
Commodities contracts — current(1)
|
$
|
320
|
|
|
$
|
2,416
|
|
|
$
|
2,266
|
|
|
$
|
12
|
|
Total derivatives
|
$
|
320
|
|
|
$
|
2,416
|
|
|
$
|
2,266
|
|
|
$
|
12
|
|
(1)
|
Derivative assets and liabilities that have settlement dates equal to or less than 12 months from the respective balance sheet date are included in prepaid expenses and other current assets and accounts payable and accrued expenses, respectively, in our unaudited Condensed Consolidated Balance Sheets.
|
•
|
Level 1 — Quoted prices for identical instruments in active markets.
|
•
|
Level 2 — Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.
|
•
|
Level 3 — Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
Fair Value as of March 31, 2017
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Asset — Commodities contracts
|
$
|
320
|
|
|
$
|
—
|
|
|
$
|
320
|
|
|
$
|
—
|
|
Liability — Commodities contracts
|
2,266
|
|
|
—
|
|
|
2,266
|
|
|
—
|
|
|
Fair Value as of December 31, 2016
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Asset — Commodities contracts
|
$
|
2,416
|
|
|
$
|
—
|
|
|
$
|
2,416
|
|
|
$
|
—
|
|
Liability — Commodities contracts
|
12
|
|
|
—
|
|
|
12
|
|
|
—
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
|
Amount Outstanding
|
|
Fair Value
|
|
Amount Outstanding
|
|
Fair Value
|
||||||||
|
(In thousands)
|
||||||||||||||
Dean Foods Company senior notes due 2023
|
$
|
700,000
|
|
|
$
|
731,500
|
|
|
$
|
700,000
|
|
|
$
|
736,750
|
|
Subsidiary senior notes due 2017
|
142,000
|
|
|
144,840
|
|
|
142,000
|
|
|
146,615
|
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Money market
|
$
|
26
|
|
|
$
|
—
|
|
|
$
|
26
|
|
|
$
|
—
|
|
Mutual funds
|
1,711
|
|
|
—
|
|
|
1,711
|
|
|
—
|
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Money market
|
$
|
27
|
|
|
$
|
—
|
|
|
$
|
27
|
|
|
$
|
—
|
|
Mutual funds
|
1,673
|
|
|
—
|
|
|
1,673
|
|
|
—
|
|
|
Employees
|
|
Non-Employee Directors
|
|
Total
|
||||||
RSUs outstanding at January 1, 2017
|
872,785
|
|
|
80,207
|
|
|
952,992
|
|
|||
RSUs granted
|
374,918
|
|
|
45,528
|
|
|
420,446
|
|
|||
Shares issued upon vesting of RSUs
|
(213,451
|
)
|
|
(37,204
|
)
|
|
(250,655
|
)
|
|||
RSUs canceled or forfeited(1)
|
(125,218
|
)
|
|
(2,112
|
)
|
|
(127,330
|
)
|
|||
RSUs outstanding at March 31, 2017
|
909,034
|
|
|
86,419
|
|
|
995,453
|
|
|||
Weighted average grant date fair value
|
$
|
18.00
|
|
|
$
|
18.46
|
|
|
$
|
18.04
|
|
(1)
|
Pursuant to the terms of our plans, employees have the option of forfeiting RSUs to cover their minimum statutory tax withholding when shares are issued. Any RSUs surrendered or canceled in satisfaction of participants’ tax withholding obligations are not available for future grants under the plans.
|
|
PSUs
|
|
Weighted Average Grant Date Fair Value
|
|||
Outstanding at January 1, 2017
|
90,583
|
|
|
$
|
19.13
|
|
Granted
|
158,402
|
|
|
18.84
|
|
|
Vested
|
—
|
|
|
—
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
Outstanding at March 31, 2017
|
248,985
|
|
|
$
|
18.94
|
|
|
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Outstanding at January 1, 2017
|
1,361,062
|
|
|
$
|
17.78
|
|
Granted
|
750,893
|
|
|
18.45
|
|
|
Converted/paid
|
(570,113
|
)
|
|
16.97
|
|
|
Forfeited
|
(51,959
|
)
|
|
18.08
|
|
|
Outstanding at March 31, 2017
|
1,489,883
|
|
|
$
|
18.42
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Contractual
Life (Years)
|
|
Aggregate
Intrinsic
Value
|
|||||
Options outstanding and exercisable at January 1, 2017
|
2,038,829
|
|
|
$
|
19.78
|
|
|
|
|
|
||
Forfeited and canceled
|
(487,971
|
)
|
|
26.07
|
|
|
|
|
|
|||
Exercised
|
(31,567
|
)
|
|
17.26
|
|
|
|
|
|
|||
Options outstanding and exercisable at March 31, 2017
|
1,519,291
|
|
|
$
|
17.81
|
|
|
1.99
|
|
$
|
4,957,607
|
|
|
Three Months Ended March 31
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands)
|
||||||
RSUs
|
$
|
1,608
|
|
|
$
|
1,369
|
|
PSUs
|
500
|
|
|
387
|
|
||
Phantom shares
|
1,849
|
|
|
4,311
|
|
||
Total
|
$
|
3,957
|
|
|
$
|
6,067
|
|
|
Three Months Ended March 31
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands, except share data)
|
||||||
Basic earnings (loss) per share computation:
|
|
||||||
Numerator:
|
|
||||||
Income (loss)
|
$
|
(9,759
|
)
|
|
$
|
39,201
|
|
Denominator:
|
|
|
|
||||
Average common shares
|
90,709,802
|
|
|
91,567,119
|
|
||
Basic earnings (loss) per share
|
$
|
(0.11
|
)
|
|
$
|
0.43
|
|
Diluted earnings (loss) per share computation:
|
|
||||||
Numerator:
|
|
||||||
Income (loss)
|
$
|
(9,759
|
)
|
|
$
|
39,201
|
|
Denominator:
|
|
|
|
||||
Average common shares — basic
|
90,709,802
|
|
|
91,567,119
|
|
||
Stock option conversion(1)
|
—
|
|
|
287,657
|
|
||
RSUs and PSUs(2)
|
—
|
|
|
313,527
|
|
||
Average common shares — diluted
|
90,709,802
|
|
|
92,168,303
|
|
||
Diluted earnings (loss) per share
|
$
|
(0.11
|
)
|
|
$
|
0.43
|
|
(1) Anti-dilutive options excluded
|
1,760,843
|
|
|
1,403,295
|
|
||
(2) Anti-dilutive stock units excluded
|
1,082,207
|
|
|
172,195
|
|
|
Pension and
Other
Postretirement
Benefits Items
|
|
Foreign
Currency
Items
|
|
Total
|
||||||
Balance at December 31, 2016
|
$
|
(84,852
|
)
|
|
$
|
(4,781
|
)
|
|
$
|
(89,633
|
)
|
Other comprehensive income before reclassifications
|
3,291
|
|
|
—
|
|
|
3,291
|
|
|||
Amounts reclassified from accumulated other comprehensive income(1)
|
(1,647
|
)
|
|
—
|
|
|
(1,647
|
)
|
|||
Net current-period other comprehensive income
|
1,644
|
|
|
—
|
|
|
1,644
|
|
|||
Balance at March 31, 2017
|
$
|
(83,208
|
)
|
|
$
|
(4,781
|
)
|
|
$
|
(87,989
|
)
|
(1)
|
The accumulated other comprehensive loss reclassification is related to amortization of unrecognized actuarial losses and prior service costs, both of which are included in the computation of net periodic benefit cost. See Note
10
.
|
|
Pension and
Other
Postretirement
Benefits Items
|
|
Foreign
Currency
Items
|
|
Total
|
||||||
Balance at December 31, 2015
|
$
|
(83,279
|
)
|
|
$
|
(2,524
|
)
|
|
$
|
(85,803
|
)
|
Other comprehensive income before reclassifications
|
2,949
|
|
|
153
|
|
|
3,102
|
|
|||
Amounts reclassified from accumulated other comprehensive income(1)
|
(1,464
|
)
|
|
—
|
|
|
(1,464
|
)
|
|||
Net current-period other comprehensive income
|
1,485
|
|
|
153
|
|
|
1,638
|
|
|||
Balance at March 31, 2016
|
$
|
(81,794
|
)
|
|
$
|
(2,371
|
)
|
|
$
|
(84,165
|
)
|
(1)
|
The accumulated other comprehensive loss reclassification is related to amortization of unrecognized actuarial losses and prior service costs, both of which are included in the computation of net periodic benefit cost. See Note
10
.
|
|
Three Months Ended March 31
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands)
|
||||||
Components of net periodic benefit cost:
|
|
|
|
||||
Service cost
|
$
|
752
|
|
|
$
|
793
|
|
Interest cost
|
2,927
|
|
|
3,043
|
|
||
Expected return on plan assets
|
(4,758
|
)
|
|
(4,633
|
)
|
||
Amortizations:
|
|
|
|
||||
Prior service cost
|
176
|
|
|
214
|
|
||
Unrecognized net loss
|
2,581
|
|
|
2,206
|
|
||
Net periodic benefit cost
|
$
|
1,678
|
|
|
$
|
1,623
|
|
|
Three Months Ended March 31
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands)
|
||||||
Components of net periodic benefit cost:
|
|
|
|
||||
Service cost
|
$
|
146
|
|
|
$
|
160
|
|
Interest cost
|
240
|
|
|
271
|
|
||
Amortizations:
|
|
|
|
||||
Prior service cost
|
23
|
|
|
23
|
|
||
Unrecognized net gain
|
(114
|
)
|
|
(61
|
)
|
||
Net periodic benefit cost
|
$
|
295
|
|
|
$
|
393
|
|
|
Three Months Ended March 31
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands)
|
||||||
Closure of facilities, net(1)
|
$
|
3,486
|
|
|
$
|
1,166
|
|
Organizational Effectiveness(2)
|
5,800
|
|
|
—
|
|
||
Facility closing and reorganization costs, net
|
$
|
9,286
|
|
|
$
|
1,166
|
|
(1)
|
Reflects charges, net of gains on the sales of assets, associated with closed facilities that were incurred in
2017
and
2016
. These charges are primarily related to facility closures in Orem, Utah; New Orleans, Louisiana; Rochester, Indiana; Riverside, California; Delta, Colorado; Denver, Colorado; Dallas, Texas; Waco, Texas; Springfield, Virginia; Buena Park, California; Evart, Michigan; Bangor, Maine; Shreveport, Louisiana; Mendon, Massachusetts; and Sheboygan, Wisconsin, as well as other approved closures. We have incurred net charges to date of
$77.3 million
related to these facility closures through
March 31, 2017
. We expect to incur additional charges related to these facility closures of approximately
$3.8 million
related to contract termination, shutdown and other costs. As we continue the evaluation of our supply chain and distribution network, it is likely that we will close additional facilities in the future.
|
(2)
|
During the first quarter of 2017, we implemented an organizational structure change within our commercial organization to better align our internal and external selling capabilities with our strategic plan. This initiative resulted in a headcount reduction in our internal selling organization, and the charges in the first quarter of 2017 are primarily comprised of severance benefits and other employee-related costs associated with this initiative. While we expect to implement similar initiatives across other functions in the coming months, those individual plans have not been finalized and approved; therefore, future costs are not yet estimable.
|
|
Accrued Charges at December 31, 2016
|
|
Charges and Adjustments
|
|
Payments
|
|
Accrued Charges at March 31, 2017
|
||||||||
|
(In thousands)
|
||||||||||||||
Cash charges:
|
|
|
|
|
|
|
|
||||||||
Workforce reduction costs
|
$
|
3,610
|
|
|
$
|
5,688
|
|
|
$
|
(428
|
)
|
|
$
|
8,870
|
|
Shutdown costs
|
—
|
|
|
1,593
|
|
|
(1,593
|
)
|
|
—
|
|
||||
Lease obligations after shutdown
|
3,932
|
|
|
69
|
|
|
(397
|
)
|
|
3,604
|
|
||||
Other
|
—
|
|
|
47
|
|
|
(47
|
)
|
|
—
|
|
||||
Subtotal
|
$
|
7,542
|
|
|
7,397
|
|
|
$
|
(2,465
|
)
|
|
$
|
12,474
|
|
|
Other charges:
|
|
|
|
|
|
|
|
||||||||
Write-down of assets(1)
|
|
|
1,816
|
|
|
|
|
|
|||||||
Loss on sale of related assets
|
|
|
67
|
|
|
|
|
|
|||||||
Other, net
|
|
|
6
|
|
|
|
|
|
|||||||
Subtotal
|
|
|
1,889
|
|
|
|
|
|
|||||||
Total
|
|
|
$
|
9,286
|
|
|
|
|
|
(1)
|
The write-down of assets relates primarily to owned buildings, land and equipment of those facilities identified for closure. The assets were tested for recoverability at the time the decision to close the facilities was more likely than not to occur. Over time, refinements to our estimates used in testing for recoverability may result in additional asset write-downs. The write-down of assets can include accelerated depreciation recorded for those facilities identified for closure. Our methodology for testing the recoverability of the assets is consistent with the methodology described in the “Asset Impairment Charges” section above.
|
|
Three Months Ended March 31
|
||||||||||||
|
2017
|
|
2016
|
||||||||||
|
Dollars
|
|
Percent
|
|
Dollars
|
|
Percent
|
||||||
|
(Dollars in millions)
|
||||||||||||
Net sales
|
$
|
1,995.7
|
|
|
100.0
|
%
|
|
$
|
1,878.8
|
|
|
100.0
|
%
|
Cost of sales
|
1,533.6
|
|
|
76.8
|
|
|
1,374.7
|
|
|
73.2
|
|
||
Gross profit(1)
|
462.1
|
|
|
23.2
|
|
|
504.1
|
|
|
26.8
|
|
||
Operating costs and expenses:
|
|
|
|
|
|
|
|
||||||
Selling and distribution
|
345.2
|
|
|
17.3
|
|
|
332.9
|
|
|
17.7
|
|
||
General and administrative
|
99.4
|
|
|
5.0
|
|
|
85.2
|
|
|
4.5
|
|
||
Amortization of intangibles
|
5.2
|
|
|
0.3
|
|
|
6.3
|
|
|
0.3
|
|
||
Facility closing and reorganization costs, net
|
9.3
|
|
|
0.5
|
|
|
1.2
|
|
|
0.1
|
|
||
Total operating costs and expenses
|
459.1
|
|
|
23.0
|
|
|
425.6
|
|
|
22.7
|
|
||
Operating income
|
$
|
3.0
|
|
|
0.2
|
%
|
|
$
|
78.5
|
|
|
4.2
|
%
|
(1)
|
As disclosed in Note
1
to the Consolidated Financial Statements in our
2016
Annual Report on Form 10-K, we include certain shipping and handling costs within selling and distribution expense. As a result, our gross profit may not be comparable to other entities that present all shipping and handling costs as a component of cost of sales.
|
|
Three Months Ended March 31, 2017 vs. 2016
|
||
|
(In millions)
|
||
Volume
|
$
|
(44.2
|
)
|
Pricing and product mix changes
|
119.5
|
|
|
Acquisitions
|
41.6
|
|
|
Total increase
|
$
|
116.9
|
|
|
Three Months Ended March 31*
|
|||||||||
|
2017
|
|
2016
|
|
% Change
|
|||||
Class I mover(1)
|
$
|
17.03
|
|
|
$
|
14.49
|
|
|
17.5
|
%
|
Class I raw skim milk mover(1)(2)
|
8.82
|
|
|
5.69
|
|
|
55.0
|
|
||
Class I butterfat mover(2)(3)
|
2.43
|
|
|
2.57
|
|
|
(5.4
|
)
|
||
Class II raw skim milk minimum(1)(4)
|
8.02
|
|
|
6.18
|
|
|
29.8
|
|
||
Class II butterfat minimum(3)(4)
|
2.46
|
|
|
2.30
|
|
|
7.0
|
|
*
|
The prices noted in this table are not the prices that we actually pay. The federal order minimum prices applicable
at any given location for Class I raw skim milk or Class I butterfat are based on the Class I mover prices plus producer premiums and a location differential. Class II prices noted in the table are federal minimum prices, applicable at all locations. Our actual cost also includes procurement costs and other related charges that vary by location and supplier. Please see “Part I — Item 1. Business — Government Regulation — Milk Industry Regulation” in our
2016
Annual Report on Form 10-K and “— Known Trends and Uncertainties — Prices of Conventional Raw Milk and Other Inputs” below for a more complete description of raw milk pricing.
|
(1)
|
Prices are per hundredweight.
|
(2)
|
We process Class I raw skim milk and butterfat into fluid milk products.
|
(3)
|
Prices are per pound.
|
(4)
|
We process Class II raw skim milk and butterfat into products such as cottage cheese, creams and creamers, ice cream and sour cream.
|
•
|
Selling and distribution costs
increase
d by
$12.3 million
during the
first
quarter of
2017
primarily due to higher fuel costs and incremental investments in logistics, partially offset by decreased advertising costs.
|
•
|
General and administrative costs
increase
d by
$14.2 million
during the
first
quarter of
2017
primarily due to the litigation settlements reached in the first quarter of 2017 and the related legal expenses.
|
•
|
Amortization of intangibles
decrease
d by
$1.1 million
during the
first
quarter of
2017
related to the extension of the useful lives of certain of our finite-lived trademarks in conjunction with our strategy around our ice cream brands in the first quarter of 2016.
|
•
|
Facility closing and reorganization costs
increase
d by
$8.1 million
during the
first
quarter of
2017
primarily due to costs associated with the implementation of our organizational structure change and additional asset write-downs and other charges associated with closed facilities. See Note
11
to our unaudited Condensed Consolidated Financial Statements.
|
|
Three Months Ended March 31
|
||||||||||
|
2017
|
|
2016
|
|
Change
|
||||||
|
(In thousands)
|
||||||||||
Net cash flows from continuing operations:
|
|
|
|
|
|
||||||
Operating activities
|
$
|
27,556
|
|
|
$
|
46,230
|
|
|
$
|
(18,674
|
)
|
Investing activities
|
(7,371
|
)
|
|
(13,858
|
)
|
|
6,487
|
|
|||
Financing activities
|
(6,583
|
)
|
|
(8,577
|
)
|
|
1,994
|
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
—
|
|
|
66
|
|
|
(66
|
)
|
|||
Net increase in cash and cash equivalents
|
$
|
13,602
|
|
|
$
|
23,861
|
|
|
$
|
(10,259
|
)
|
|
Payments Due by Period
|
||||||||||||||||||||||||||
|
Total
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
||||||||||||||
|
(in millions)
|
||||||||||||||||||||||||||
Receivables securitization facility(1)
|
$
|
50.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
50.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Credit Facility(1)
|
4.4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4.4
|
|
|||||||
Interest payments(2)
|
325.5
|
|
|
60.6
|
|
|
50.8
|
|
|
50.8
|
|
|
47.5
|
|
|
47.5
|
|
|
68.3
|
|
|||||||
Total
|
$
|
379.9
|
|
|
$
|
60.6
|
|
|
$
|
50.8
|
|
|
$
|
50.8
|
|
|
$
|
97.5
|
|
|
$
|
47.5
|
|
|
$
|
72.7
|
|
(1)
|
Represents amounts outstanding under our receivables securitization facility and Credit Facility at March 31, 2017. On January 4, 2017, we amended our receivables purchase agreement to extend the maturity date to January 4, 2020, and we amended our Credit Agreement to extend the maturity date to January 4, 2022. See Note
5
to our unaudited Condensed Consolidated Financial Statements for additional information regarding the January 4, 2017 amendments to the receivables purchase agreement and the Credit Agreement.
|
(2)
|
Includes fixed rate interest obligations and interest on variable rate debt based on the outstanding balances and interest rates in effect at March 31, 2017. Interest that may be due in the future on variable rate borrowings under the Credit Facility and receivables securitization facility will vary based on the interest rate in effect at the time and the borrowings outstanding at the time. On January 4, 2017, we amended the purchase agreement governing the receivables securitization facility to modify certain pricing terms such that advances outstanding under the receivables securitization facility will bear interest between 0.90% and 1.05%, and the Company will pay an unused fee between 0.40% and 0.55% on undrawn amounts, in each case based on the Company's total net leverage ratio. On January 4, 2017, we amended the Credit Agreement to modify the definition of “Applicable Rate” to reduce the interest rate margins such that loans outstanding under the Credit Facility will bear interest, at our option, at either (x) the LIBO Rate (as defined in the Credit Agreement) plus a margin of between 1.75% and 2.50% based on our total net leverage ratio, or (y) the Alternate Base Rate (as defined in the Credit Agreement) plus a margin of between 0.75% and 1.50% based on our total net leverage ratio. See Note
5
to our unaudited Condensed Consolidated Financial Statements for additional information regarding the January 4, 2017 amendments to the receivables purchase agreement and the Credit Agreement.
|
•
|
certain indemnification obligations related to businesses that we have divested;
|
•
|
certain lease obligations, which require us to guarantee the minimum value of the leased asset at the end of the lease;
|
•
|
selected levels of property and casualty risks, primarily related to employee health care, workers’ compensation claims and other casualty losses; and
|
•
|
certain litigation-related contingencies.
|
10.1
|
Second Amendment to Credit Agreement, dated as of January 4, 2017, by and among Dean Foods Company; the subsidiary guarantors thereto; the lenders listed on the signature pages thereof; and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on January 6, 2017).
|
10.2
|
Amendment No. 1 to Seventh Amended and Restated Receivables Purchase Agreement, dated as of January 4, 2017, among Dairy Group Receivables L.P. and Dairy Group Receivables II, L.P., as Sellers; the Servicers, Companies and Financial Institutions listed therein; and Cooperatieve Rabobank U.A., New York Branch, as Agent (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed on January 6, 2017).
|
10.3
|
Dean Foods Company 2017 Short-Term Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on March 10, 2017).
|
31.1
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
31.2
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
32.1
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
32.2
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
99
|
Supplemental Financial Information for Dean Holding Company (filed herewith).
|
|
|
101.INS XBRL Instance Document(1).
|
|
101.SCH XBRL Taxonomy Extension Schema Document(1).
|
|
101.CAL XBRL Taxonomy Calculation Linkbase Document(1).
|
|
101.DEF XBRL Taxonomy Extension Definition Linkbase Document(1).
|
|
101.LAB XBRL Taxonomy Label Linkbase Document(1).
|
|
101.PRE XBRL Taxonomy Presentation Linkbase Document(1).
|
(1)
|
Filed electronically herewith.
|
|
DEAN FOODS COMPANY
|
|
|
|
/
S
/ S
COTT
K. V
OPNI
|
|
Scott K. Vopni
|
|
Senior Vice President, Finance and Chief Accounting Officer
|
10.1
|
Second Amendment to Credit Agreement, dated as of January 4, 2017, by and among Dean Foods Company; the subsidiary guarantors thereto; the lenders listed on the signature pages thereof; and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on January 6, 2017).
|
10.2
|
Amendment No. 1 to Seventh Amended and Restated Receivables Purchase Agreement, dated as of January 4, 2017, among Dairy Group Receivables L.P. and Dairy Group Receivables II, L.P., as Sellers; the Servicers, Companies and Financial Institutions listed therein; and Cooperatieve Rabobank U.A., New York Branch, as Agent (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed on January 6, 2017).
|
10.3
|
Dean Foods Company 2017 Short-Term Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on March 10, 2017).
|
31.1
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
31.2
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
32.1
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
32.2
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
99
|
Supplemental Financial Information for Dean Holding Company (filed herewith).
|
|
|
101.INS XBRL Instance Document(1).
|
|
101.SCH XBRL Taxonomy Extension Schema Document(1).
|
|
101.CAL XBRL Taxonomy Calculation Linkbase Document(1).
|
|
101.DEF XBRL Taxonomy Extension Definition Linkbase Document(1).
|
|
101.LAB XBRL Taxonomy Label Linkbase Document(1).
|
|
101.PRE XBRL Taxonomy Presentation Linkbase Document(1).
|
(1)
|
Filed electronically herewith.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Supplier name | Ticker |
---|---|
Ecolab Inc. | ECL |
CSX Corporation | CSX |
Illinois Tool Works Inc. | ITW |
Ball Corporation | BLL |
The Kraft Heinz Company | KHC |
McCormick & Company, Incorporated | MKC |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|